Copyright Reports & Markets. All rights reserved.

Global Fluorescein Sodium Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Fluorescein Sodium Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 100 mg/1mL
    • 1.3.3 250 mg/1mL
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Fluorescein Sodium Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Fluorescein Sodium Injection Market Size & Forecast
    • 1.5.1 Global Fluorescein Sodium Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Fluorescein Sodium Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Fluorescein Sodium Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 SERB Pharmaceuticals
    • 2.1.1 SERB Pharmaceuticals Details
    • 2.1.2 SERB Pharmaceuticals Major Business
    • 2.1.3 SERB Pharmaceuticals Fluorescein Sodium Injection Product and Services
    • 2.1.4 SERB Pharmaceuticals Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 SERB Pharmaceuticals Recent Developments/Updates
  • 2.2 Alcon
    • 2.2.1 Alcon Details
    • 2.2.2 Alcon Major Business
    • 2.2.3 Alcon Fluorescein Sodium Injection Product and Services
    • 2.2.4 Alcon Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Alcon Recent Developments/Updates
  • 2.3 Akorn
    • 2.3.1 Akorn Details
    • 2.3.2 Akorn Major Business
    • 2.3.3 Akorn Fluorescein Sodium Injection Product and Services
    • 2.3.4 Akorn Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Akorn Recent Developments/Updates
  • 2.4 Alliance LLC
    • 2.4.1 Alliance LLC Details
    • 2.4.2 Alliance LLC Major Business
    • 2.4.3 Alliance LLC Fluorescein Sodium Injection Product and Services
    • 2.4.4 Alliance LLC Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Alliance LLC Recent Developments/Updates
  • 2.5 Odan Laboratories Ltd
    • 2.5.1 Odan Laboratories Ltd Details
    • 2.5.2 Odan Laboratories Ltd Major Business
    • 2.5.3 Odan Laboratories Ltd Fluorescein Sodium Injection Product and Services
    • 2.5.4 Odan Laboratories Ltd Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Odan Laboratories Ltd Recent Developments/Updates
  • 2.6 Zuellig Pharma
    • 2.6.1 Zuellig Pharma Details
    • 2.6.2 Zuellig Pharma Major Business
    • 2.6.3 Zuellig Pharma Fluorescein Sodium Injection Product and Services
    • 2.6.4 Zuellig Pharma Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Zuellig Pharma Recent Developments/Updates
  • 2.7 Altaire Pharmaceuticals
    • 2.7.1 Altaire Pharmaceuticals Details
    • 2.7.2 Altaire Pharmaceuticals Major Business
    • 2.7.3 Altaire Pharmaceuticals Fluorescein Sodium Injection Product and Services
    • 2.7.4 Altaire Pharmaceuticals Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Altaire Pharmaceuticals Recent Developments/Updates
  • 2.8 Bausch & Lomb U.K Limited
    • 2.8.1 Bausch & Lomb U.K Limited Details
    • 2.8.2 Bausch & Lomb U.K Limited Major Business
    • 2.8.3 Bausch & Lomb U.K Limited Fluorescein Sodium Injection Product and Services
    • 2.8.4 Bausch & Lomb U.K Limited Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bausch & Lomb U.K Limited Recent Developments/Updates
  • 2.9 Guangxi Wuzhou Pharmaceutical
    • 2.9.1 Guangxi Wuzhou Pharmaceutical Details
    • 2.9.2 Guangxi Wuzhou Pharmaceutical Major Business
    • 2.9.3 Guangxi Wuzhou Pharmaceutical Fluorescein Sodium Injection Product and Services
    • 2.9.4 Guangxi Wuzhou Pharmaceutical Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Guangxi Wuzhou Pharmaceutical Recent Developments/Updates
  • 2.10 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
    • 2.10.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Details
    • 2.10.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Major Business
    • 2.10.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Fluorescein Sodium Injection Product and Services
    • 2.10.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Fluorescein Sodium Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Fluorescein Sodium Injection by Manufacturer

  • 3.1 Global Fluorescein Sodium Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Fluorescein Sodium Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Fluorescein Sodium Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Fluorescein Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Fluorescein Sodium Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Fluorescein Sodium Injection Manufacturer Market Share in 2025
  • 3.5 Fluorescein Sodium Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Fluorescein Sodium Injection Market: Region Footprint
    • 3.5.2 Fluorescein Sodium Injection Market: Company Product Type Footprint
    • 3.5.3 Fluorescein Sodium Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Fluorescein Sodium Injection Market Size by Region
    • 4.1.1 Global Fluorescein Sodium Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Fluorescein Sodium Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Fluorescein Sodium Injection Average Price by Region (2021-2032)
  • 4.2 North America Fluorescein Sodium Injection Consumption Value (2021-2032)
  • 4.3 Europe Fluorescein Sodium Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Fluorescein Sodium Injection Consumption Value (2021-2032)
  • 4.5 South America Fluorescein Sodium Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Fluorescein Sodium Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Fluorescein Sodium Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Fluorescein Sodium Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Fluorescein Sodium Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Fluorescein Sodium Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Fluorescein Sodium Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Fluorescein Sodium Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Fluorescein Sodium Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Fluorescein Sodium Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Fluorescein Sodium Injection Market Size by Country
    • 7.3.1 North America Fluorescein Sodium Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Fluorescein Sodium Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Fluorescein Sodium Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Fluorescein Sodium Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Fluorescein Sodium Injection Market Size by Country
    • 8.3.1 Europe Fluorescein Sodium Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Fluorescein Sodium Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Fluorescein Sodium Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Fluorescein Sodium Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Fluorescein Sodium Injection Market Size by Region
    • 9.3.1 Asia-Pacific Fluorescein Sodium Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Fluorescein Sodium Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Fluorescein Sodium Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Fluorescein Sodium Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Fluorescein Sodium Injection Market Size by Country
    • 10.3.1 South America Fluorescein Sodium Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Fluorescein Sodium Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Fluorescein Sodium Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Fluorescein Sodium Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Fluorescein Sodium Injection Market Size by Country
    • 11.3.1 Middle East & Africa Fluorescein Sodium Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Fluorescein Sodium Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Fluorescein Sodium Injection Market Drivers
  • 12.2 Fluorescein Sodium Injection Market Restraints
  • 12.3 Fluorescein Sodium Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Fluorescein Sodium Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Fluorescein Sodium Injection
  • 13.3 Fluorescein Sodium Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Fluorescein Sodium Injection Typical Distributors
  • 14.3 Fluorescein Sodium Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fluorescein Sodium Injection market size was valued at US$ 134 million in 2025 and is forecast to a readjusted size of US$ 186 million by 2032 with a CAGR of 4.9% during review period.
    For diagnostic fluorescein angiography or angioscopy of the retinal and iris vasculature.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Fluorescein Sodium Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Fluorescein Sodium Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Fluorescein Sodium Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Fluorescein Sodium Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Fluorescein Sodium Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Fluorescein Sodium Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Fluorescein Sodium Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SERB Pharmaceuticals, Alcon, Akorn, Alliance LLC, Odan Laboratories Ltd, Zuellig Pharma, Altaire Pharmaceuticals, Bausch & Lomb U.K Limited, Guangxi Wuzhou Pharmaceutical, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Fluorescein Sodium Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    100 mg/1mL
    250 mg/1mL
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    SERB Pharmaceuticals
    Alcon
    Akorn
    Alliance LLC
    Odan Laboratories Ltd
    Zuellig Pharma
    Altaire Pharmaceuticals
    Bausch & Lomb U.K Limited
    Guangxi Wuzhou Pharmaceutical
    Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Fluorescein Sodium Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Fluorescein Sodium Injection, with price, sales quantity, revenue, and global market share of Fluorescein Sodium Injection from 2021 to 2026.
    Chapter 3, the Fluorescein Sodium Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Fluorescein Sodium Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Fluorescein Sodium Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescein Sodium Injection.
    Chapter 14 and 15, to describe Fluorescein Sodium Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now